Xiaofeng Wang

Glutazumab, a novel long‐lasting GLP‐1/anti‐GLP‐1R antibody fusion protein, exerts anti‐diabetic effects through targeting dual receptor binding sites

Shuainan Liu, Quan Liu, Z. Shen, 2018, Biochemical pharmacology.

Mechanistic Pharmacokinetic/Target Engagement/Pharmacodynamic (PK/TE/PD) Modeling in Deciphering Interplay Between a Monoclonal Antibody and Its Soluble Target in Cynomolgus Monkeys

Honghui Zhou, Weirong Wang, Xiaofeng Wang, 2013, The AAPS Journal.

Efficacy and safety of glibenclamide therapy after intracerebral haemorrhage (GATE-ICH): A multicentre, prospective, randomised, controlled, open-label, blinded-endpoint, phase 2 clinical trial

Fang Yang, Jing-jing Zhao, Wen Jiang, 2022, EClinicalMedicine.

Determination of parameters responsible for pharmacokinetic behavior of TCDD in female Sprague-Dawley rats.

L. Birnbaum, M. Santostefano, M. Evans, 1997, Toxicology and applied pharmacology.

A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: dose- and time-dependent effects.

M. DeVito, L. Birnbaum, M. Santostefano, 1998, Toxicology and applied pharmacology.

A PBPK model describing a xenobiotic with a short PK event scale

B. Davies, Xiaofeng Wang, 2015, Journal of Pharmacokinetics and Pharmacodynamics.